Hospital
Sweetwater Hospital Association
Sweetwater Hospital Association was paid $12.94M by Medicaid between Jan 2018 and Dec 2024, across 196 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.
33Billing provider infoSWEETWATER HOSPITAL ASSOCIATION
SWEETWATER, TN 37874
SWEETWATER, TN 37874
33aNPI1366441370assigned 07/20/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.94M
24GClaims694,159
24DCodes billed196
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#23 of 71
Median peer was paid$6.96M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 104,149 | $2.22M | |
| 2019 | 107,048 | $2.26M | |
| 2020 | 80,456 | $1.53M | |
| 2021 | 88,896 | $1.58M | |
| 2022 | 101,401 | $1.67M | |
| 2023 | 132,282 | $2.22M | |
| 2024incomplete | 79,927 | $1.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 20,767 | 16,015 | $3.77M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 20,805 | 17,028 | $3.20M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11% | 12,704 | 10,712 | $1.45M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8.5% | 44,218 | 34,123 | $1.10M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.5% | 1,711 | 1,412 | $451K |
| 76376 | 2.3% | 14,055 | 12,152 | $298K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 26,875 | 21,089 | $233K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 54,531 | 43,343 | $212K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.4% | 2,812 | 2,589 | $186K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.4% | 1,106 | 885 | $176K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,318 | 3,796 | $111K |
| 84484 | <1% | 12,745 | 8,957 | $100K |
184 more codes
| 80053 | Comprehensive metabolic panel | <1% | 48,736 | $96K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 8,413 | $93K |
| 36415 | Collection of venous blood by venipuncture | <1% | 72,226 | $87K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 17,528 | $78K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,929 | $73K |
| 94760 | <1% | 32,167 | $65K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,369 | $61K |
| 80306 | <1% | 10,256 | $51K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,562 | $47K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,982 | $46K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,928 | $40K |
| 80061 | Lipid panel | <1% | 11,550 | $39K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,097 | $38K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 13,312 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,274 | $36K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,083 | $35K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 587 | $34K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,264 | $32K |
| 81002 | <1% | 9,923 | $30K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,905 | $27K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,317 | $23K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 887 | $22K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 68 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,842 | $22K |
| 84703 | <1% | 4,644 | $22K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 692 | $20K |
| 85730 | <1% | 8,198 | $19K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,319 | $18K |
| 87081 | <1% | 4,499 | $17K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,645 | $17K |
| 87428 | <1% | 596 | $17K | |
| 81001 | <1% | 26,598 | $16K | |
| 83874 | <1% | 3,420 | $15K | |
| 72110 | <1% | 655 | $14K | |
| 84702 | <1% | 936 | $14K | |
| 93041 | <1% | 16,354 | $14K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 405 | $13K |
| 85610 | <1% | 8,403 | $13K | |
| 83690 | <1% | 3,566 | $13K | |
| 59025 | Fetal non-stress test | <1% | 441 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,479 | $13K |
| 82150 | <1% | 3,476 | $12K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 74 | $12K |
| 87070 | <1% | 2,123 | $11K | |
| 43235 | <1% | 42 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 193 | $11K |
| 86900 | <1% | 767 | $11K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 266 | $10K |
| 85379 | <1% | 1,981 | $10K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 442 | $10K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 14 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,257 | $9K |
| 83735 | <1% | 3,418 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 699 | $7K |
| 99442 | <1% | 212 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 710 | $7K |
| 86850 | <1% | 705 | $6K | |
| 84439 | <1% | 2,880 | $5K | |
| 87430 | <1% | 561 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 256 | $4K |
| 90686 | <1% | 545 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 243 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,689 | $4K |
| 85018 | <1% | 1,697 | $4K | |
| 87040 | <1% | 1,020 | $4K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 6,403 | $4K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 7,954 | $4K |
| 82607 | <1% | 779 | $3K | |
| 73562 | <1% | 249 | $3K | |
| 83655 | <1% | 209 | $3K | |
| 86592 | <1% | 816 | $2K | |
| 73110 | <1% | 142 | $2K | |
| 86171 | <1% | 248 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 555 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 734 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 29 | $2K |
| 82951 | <1% | 199 | $2K | |
| 0031A | <1% | 66 | $2K | |
| 86803 | <1% | 266 | $2K | |
| 96376 | <1% | 347 | $1K | |
| 85027 | <1% | 463 | $1K | |
| 85652 | <1% | 765 | $1K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 21 | $1K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 28 | $1K |
| 73564 | <1% | 64 | $1K | |
| 73610 | <1% | 91 | $1K | |
| 83970 | <1% | 127 | $1K | |
| 73030 | <1% | 93 | $1K | |
| 86762 | <1% | 288 | $985.65 | |
| J1380 | Injection, estradiol valerate, up to 10 mg | <1% | 451 | $888.27 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 1,024 | $882.08 |
| 83540 | <1% | 1,023 | $870.24 | |
| 87340 | <1% | 259 | $812.44 | |
| 86706 | <1% | 137 | $737.59 | |
| 0011A | <1% | 40 | $689.38 | |
| 0012A | <1% | 22 | $680.00 | |
| 73130 | <1% | 35 | $627.98 | |
| 83605 | <1% | 171 | $581.56 | |
| 90670 | <1% | 60 | $573.80 | |
| 82947 | <1% | 138 | $551.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 16 | $527.66 |
| 73630 | <1% | 66 | $514.31 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $486.88 |
| 82948 | <1% | 288 | $470.44 | |
| 86140 | <1% | 505 | $468.21 | |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $439.90 |
| 87184 | <1% | 136 | $410.91 | |
| 84550 | <1% | 405 | $381.81 | |
| 84681 | <1% | 21 | $371.59 | |
| 81025 | <1% | 101 | $342.38 | |
| 90715 | <1% | 27 | $333.60 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 4,364 | $326.52 |
| 83525 | <1% | 53 | $317.90 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 17 | $305.87 |
| 83880 | <1% | 41 | $294.80 | |
| 86038 | <1% | 227 | $287.02 | |
| 80069 | <1% | 211 | $260.69 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 51 | $241.62 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 18 | $237.80 |
| 82803 | <1% | 43 | $189.90 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 103 | $173.10 |
| 82728 | <1% | 55 | $169.85 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 358 | $157.03 |
| 87510 | <1% | 22 | $138.66 | |
| 81003 | <1% | 332 | $138.65 | |
| 82677 | <1% | 12 | $135.93 | |
| 82105 | <1% | 26 | $116.46 | |
| 87480 | <1% | 17 | $111.18 | |
| 87660 | <1% | 17 | $98.99 | |
| 86336 | <1% | 12 | $87.59 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 13 | $85.93 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,052 | $84.93 |
| 85732 | <1% | 14 | $84.82 | |
| G0378 | Hospital observation service, per hour | <1% | 292 | $81.29 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 17 | $77.64 |
| 82652 | <1% | 13 | $76.29 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 134 | $71.04 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 97 | $69.87 |
| 82570 | <1% | 184 | $67.90 | |
| 82043 | <1% | 244 | $67.24 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 193 | $59.28 |
| 87522 | Neg quan hep c or qual rna | <1% | 30 | $56.58 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 15 | $44.82 |
| 96523 | <1% | 28 | $43.12 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 76 | $42.80 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 41 | $39.38 |
| 84436 | <1% | 41 | $38.78 | |
| G0008 | Administration of influenza virus vaccine | <1% | 587 | $28.92 |
| 84480 | <1% | 13 | $28.08 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,412 | $24.30 |
| 86255 | <1% | 21 | $23.88 | |
| 85597 | <1% | 14 | $23.74 | |
| 90662 | <1% | 57 | $15.46 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 45 | $13.60 |
| 85613 | <1% | 14 | $12.64 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,900 | $10.61 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,931 | $7.56 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,128 | $7.09 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,123 | $6.30 |
| 83550 | <1% | 15 | $5.77 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 230 | $5.74 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,643 | $4.18 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 305 | $3.77 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 578 | $0.01 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 389 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 1,454 | $0.00 |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 201 | $0.00 |
| J2950 | Injection, promazine hcl, up to 25 mg | 0% | 2,207 | $0.00 |
| 86709 | 0% | 12 | $0.00 | |
| J0595 | Injection, butorphanol tartrate, 1 mg | 0% | 740 | $0.00 |
| 88313 | 0% | 47 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 16 | $0.00 |
| 84460 | 0% | 12 | $0.00 | |
| 96367 | 0% | 19 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 70 | $0.00 |
| 0502F | 0% | 73 | $0.00 | |
| 86705 | 0% | 12 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 127 | $0.00 |
| 1126F | 0% | 272 | $0.00 | |
| 1125F | 0% | 76 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 16 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 15 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 29 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMPSON, DEBBIE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Sweetwater Hospital Er Physician Group | Sweetwater, TN | $1.55M |
| Wendy Saint Robbins, Pediatric, PLLC | Sweetwater, TN | $663K |
| S&T Beverley, LLC | Madisonville, TN | $224K |
| Christopher S Bowman MD PC | Sweetwater, TN | $121K |
| Sweetwater Hospital Association | Sweetwater, TN | $80K |
| Sweetwater Hospital Association | Sweetwater, TN | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.